Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells

Journal of Experimental and Clinical Cancer Research

Volumn 32, Issue 1, 2013, Pages

  Xu, Yang ^a,b,c,d   Shi, Ying ^a,b,c   Yuan, Qi ^a,b,c,d   Liu, Xuli ^a,b,c,d   Yan, Bin ^a,b,c   Chen, Ling ^a,b,c   Tao, Yongguang ^a,b,c   Cao, Ya ^a,b,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c BEIJING HOSPITAL   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cyclin D1; EGFR; Epstein Barr virus; Latent membrane protein 1; Nasopharyngeal carcinoma; STAT3

Indexed keywords

ALPHA TUBULIN; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN G; LATENT MEMBRANE PROTEIN 1; MESSENGER RNA; STAT3 PROTEIN;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL LYSATE; CELL STRAIN CNE1; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; IMMUNOPRECIPITATION; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UPREGULATION; WESTERN BLOTTING;

CELL GROWTH PROCESSES; CELL LINE, TUMOR; CYCLIN D1; HERPESVIRUS 4, HUMAN; HUMANS; NASOPHARYNGEAL NEOPLASMS; PROMOTER REGIONS, GENETIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSFECTION; VIRAL MATRIX PROTEINS;

EID: 84887397619     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-32-90     Document Type: Article

References (73)

1. Epstein-Barr virus transforming proteins: biologic properties and contribution to oncogenesis. Raab-Traub N, DNA tumor viruses New York, NY: Springer, Damania B, Pipas JM, 2009 259 284
2. Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy. Strong MJ, Xu G, Coco J, Baribault C, Vinay DS, Lacey MR, Strong AL, Lehman TA, Seddon MB, Lin Z, et al. PLoS Pathog 2013 9 5 1003341 10.1371/journal.ppat. 1003341 23671415
3. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. van Beek J, zur Hausen A, Klein Kranenbarg E, van de Velde CJ, Middeldorp JM, van den Brule AJ, Meijer CJ, Bloemena E, J Clin Oncol 2004 22 4 664 670 10.1200/JCO.2004.08.061 14966089 (Pubitemid 41095069)
4. The comparison of the prognosis between Epstein-Barr virus (EBV)-positive gastric carcinomas and EBV-negative ones. Kijima Y, Ishigami S, Hokita S, Koriyama C, Akiba S, Eizuru Y, Aikou T, Cancer Lett 2003 200 1 33 40 10.1016/S0304-3835(03)00410-5 14550950 (Pubitemid 37222356)
5. Epstein-Barr virus (EBV) genes expression in cervical intraepithelial neoplasia and invasive cervical cancer: a comparative study with human papillomavirus (HPV) infection. Sasagawa T, Shimakage M, Nakamura M, Sakaike J, Ishikawa H, Inoue M, Hum Pathol 2000 31 3 318 326 10.1016/S0046-8177(00)80245-2 10746674 (Pubitemid 30161350)
6. Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. Schmauz R, Okong P, de Villiers EM, Dennin R, Brade L, Lwanga SK, Owor R, Int J Cancer 1989 43 5 805 809 10.1002/ijc.2910430511 2714885 (Pubitemid 19138185)
7. Correlation of viral factors with cervical cancer in Taiwan. Yang YY, Koh LW, Tsai JH, Tsai CH, Wong EF, Lin SJ, Yang CC, J Microbiol Immunol Infect 2004 37 5 282 287 15497009 (Pubitemid 39446667)
8. Esophageal cancer in Germany is associated with Epstein-Barr-virus but not with papillomaviruses. Awerkiew S, Bollschweiler E, Metzger R, Schneider PM, Holscher AH, Pfister H, Med Microbiol Immunol 2003 192 3 137 140 10.1007/s00430-002-0128-z 12920588 (Pubitemid 37100657)
9. Human papillomavirus and Epstein Barr virus in prostate cancer: koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancer. Whitaker NJ, Glenn WK, Sahrudin A, Orde MM, Delprado W, Lawson JS, Prostate 2013 73 3 236 241 10.1002/pros.22562 22851253
10. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P, et al. Int J Cancer 1988 42 3 329 338 10.1002/ijc.2910420305 2843473
11. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB, J Gen Virol 1988 69 Pt 5 1051 1065 2836550
12. Presence of Epstein-Barr virus latent membrane protein 1 gene in the nasopharyngeal swabs from patients with nasopharyngeal carcinoma. Lin SY, Tsang NM, Kao SC, Hsieh YL, Chen YP, Tsai CS, Kuo TT, Hao SP, Chen IH, Hong JH, Head Neck 2001 23 3 194 200 10.1002/1097-0347(200103)23:3<194::AID-HED1018>3.0. CO;2-X 11428449
13. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N, N Engl J Med 1995 333 11 693 698 10.1056/NEJM199509143331103 7637746
14. The significance of LMP1 expression in nasopharyngeal carcinoma. Tsao SW, Tramoutanis G, Dawson CW, Lo AK, Huang DP, Semin Cancer Biol 2002 12 6 473 487 10.1016/S1044579X02000901 12450733 (Pubitemid 35370760)
15. Epstein-Barr virus-encoded LMP1 triggers regulation of the ERK-mediated Op18/stathmin signaling pathway in association with cell cycle. Lin X, Tang M, Tao Y, Li L, Liu S, Guo L, Li Z, Ma X, Xu J, Cao Y, Cancer Sci 2012 103 6 993 999 10.1111/j.1349-7006.2012.02271.x 22417000
16. EBV-encoded LMP1 upregulates Igkappa 3′enhancer activity and Igkappa expression in nasopharyngeal cancer cells by activating the Ets-1 through ERKs signaling. Liu H, Duan Z, Zheng H, Hu D, Li M, Tao Y, Bode AM, Dong Z, Cao Y, PLoS One 2012 7 3 32624 10.1371/journal.pone.0032624 22396784
17. Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-kappaB regulated ATM expression. Ma X, Yang L, Xiao L, Tang M, Liu L, Li Z, Deng M, Sun L, Cao Y, PLoS One 2011 6 11 24647 10.1371/journal.pone. 0024647 22096476
18. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Zheng H, Li LL, Hu DS, Deng XY, Cao Y, Cell Mol Immunol 2007 4 3 185 196 17601372
19. A therapeutic approach to nasopharyngeal carcinomas by DNAzymes targeting EBV LMP-1 gene. Yang L, Lu Z, Ma X, Cao Y, Sun LQ, Molecules 2010 15 9 6127 6139 10.3390/molecules15096127 20877211
20. Human tumor virus utilizes exosomes for intercellular communication. Meckes DG Jr, Shair KH, Marquitz AR, Kung CP, Edwards RH, Raab-Traub N, Proc Natl Acad Sci USA 2010 107 47 20370 20375 10.1073/pnas.1014194107 21059916
21. Increase of EGFR expression by Epstein-Barr virus LMP1 in nasopharyngeal carcinoma cells. Wang C, Li X, Gu H, Zhonghua Zhong Liu Za Zhi 2001 23 4 269 272 11783104
22. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner. Tao YG, Tan YN, Liu YP, Song X, Zeng L, Gu HH, Tang M, Li W, Yi W, Cao Y, Cell Signal 2004 16 7 781 790 10.1016/j.cellsig.2003.12.001 15115657 (Pubitemid 38534527)
23. Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1. Tao Y, Song X, Deng X, Xie D, Lee LM, Liu Y, Li W, Li L, Deng L, Wu Q, et al. Exp Cell Res 2005 303 2 240 251 10.1016/j.yexcr.2004.09.030 15652339 (Pubitemid 40126259)
24. Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. Dittmann K, Mayer C, Kehlbach R, Rodemann HP, Mol Cancer 2008 7 69 10.1186/1476-4598-7-69 18789131
25. Tyrosine phosphorylation controls PCNA function through protein stability. Wang SC, Nakajima Y, Yu YL, Xia W, Chen CT, Yang CC, McIntush EW, Li LY, Hawke DH, Kobayashi R, et al. Nat Cell Biol 2006 8 12 1359 1368 10.1038/ncb1501 17115032 (Pubitemid 44835110)
26. ErbB receptors: new insights on mechanisms and biology. Linggi B, Carpenter G, Trends Cell Biol 2006 16 12 649 656 10.1016/j.tcb.2006.10.008 17085050 (Pubitemid 44809890)
27. Nuclear EGFR contributes to acquired resistance to cetuximab. Li C, Iida M, Dunn EF, Ghia AJ, Wheeler DL, Oncogene 2009 28 43 3801 3813 10.1038/onc.2009.234 19684613
28. Nuclear trafficking of the epidermal growth factor receptor family membrane proteins. Wang YN, Yamaguchi H, Hsu JM, Hung MC, Oncogene 2010 29 28 3997 4006 10.1038/onc.2010.157 20473332
29. Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations. Han W, Lo HW, Cancer Lett 2012 318 2 124 134 10.1016/j.canlet.2012.01.011 22261334
30. A census of amplified and overexpressed human cancer genes. Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS, Nat Rev Cancer 2010 10 1 59 64 20029424
31. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Lo HW, Hsu SC, Ali-Seyed M, Gunduz M, Xia W, Wei Y, Bartholomeusz G, Shih JY, Hung MC, Cancer Cell 2005 7 6 575 589 10.1016/j.ccr.2005.05.007 15950906 (Pubitemid 40799250)
32. Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis. Hsiao JR, Jin YT, Tsai ST, Shiau AL, Wu CL, Su WC, Br J Cancer 2003 89 2 344 349 10.1038/sj.bjc.6601003 12865928 (Pubitemid 36976326)
33. Role of STAT3/5 and Bcl-2/xL in 2-methoxyestradiol-induced endoreduplication of nasopharyngeal carcinoma cells. Ting CM, Wong CK, Wong RN, Lo KW, Lee AW, Tsao GS, Lung ML, Mak NK, Mol Carcinog 2011 51 12 963 972 22006341
34. STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling. Wang Z, Luo F, Li L, Yang L, Hu D, Ma X, Lu Z, Sun L, Cao Y, Eur J Cancer 2010 46 16 2996 3006 10.1016/j.ejca.2010.07.008 20709526
35. Phosphorylation and nuclear translocation of STAT3 regulated by the Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma. Liu YP, Tan YN, Wang ZL, Zeng L, Lu ZX, Li LL, Luo W, Tang M, Cao Y, Int J Mol Med 2008 21 2 153 162 18204781 (Pubitemid 351222848)
36. Differential expression of decorin, EGFR and cyclin D1 during mammary gland carcinogenesis in TA2 mice with spontaneous breast cancer. Gu Y, Zhang S, Wu Q, Xu S, Cui Y, Yang Z, Zhao X, Sun B, J Exp Clin Cancer Res 2010 29 6 10.1186/1756-9966-29-6 20092659
37. Cell cycle proteins in laryngeal cancer: role in proliferation and prognosis. Peschos D, Stefanou D, Vougiouklakis T, Assimakopoulos DA, Agnantis NJ, J Exp Clin Cancer Res 2005 24 3 431 437 16270530 (Pubitemid 41416128)
38. The Esptein-Barr virus encoded latent membrane protein 1 (EBV-LMP1) activates expression of cyclinD1. Zhao XR, Wang CX, Luo FJ, Gu HH, Tang M, Xia LQ, Deng L, Yi W, Deng XY, Cao Y, Prog Biochem Biophys 2001 28 5 704 709
39. Epstein-Barr virus-encoded latent membrane protein 1 modulates cyclin D1 by c-Jun/Jun B heterodimers. Song X, Tao Y, Zeng L, Yang J, Tang F, Lee LM, Gong J, Wu Q, Cao Y, Sci China C Life Sci 2005 48 4 385 393 10.1360/03yc0251 16248432 (Pubitemid 44112646)
40. Nuclear epidermal growth factor receptor interacts with transcriptional intermediary factor 2 to activate cyclin D1 gene expression triggered by the oncoprotein latent membrane protein 1. Shi Y, Tao Y, Jiang Y, Xu Y, Yan B, Chen X, Xiao L, Cao Y, Carcinogenesis 2012 33 8 1468 1478 10.1093/carcin/bgs171 22581837
41. Epstein-Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-kappaB p65 in human nasopharyngeal carcinoma cells. Ding L, Li LL, Yang J, Tao YG, Ye M, Shi Y, Tang M, Yi W, Li XL, Gong JP, et al. Int J Biochem Cell Biol 2005 37 9 1881 1889 10.1016/j.biocel.2005.04.012 15967702
42. Regulation of survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines. Ai MD, Li LL, Zhao XR, Wu Y, Gong JP, Cao Y, Cell Res 2005 15 10 777 784 10.1038/sj.cr.7290347 16246267 (Pubitemid 41653915)
43. LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells. Liu H, Zheng H, Duan Z, Hu D, Li M, Liu S, Li Z, Deng X, Wang Z, Tang M, et al. Mol Cancer 2009 8 92 10.1186/1476-4598-8-92 19860880
44. Stat3 isoforms, alpha and beta, demonstrate distinct intracellular dynamics with prolonged nuclear retention of Stat3beta mapping to its unique C-terminal end. Huang Y, Qiu J, Dong S, Redell MS, Poli V, Mancini MA, Tweardy DJ, J Biol Chem 2007 282 48 34958 34967 10.1074/jbc.M704548200 17855361 (Pubitemid 350232477)
45. EB virus encoded latent membrane protein 1 modulates the phosphorylation of epidermal growth factor receptor in nasopharyngeal carcinoma cell line. Tao Y, Deng X, Hu Z, Tang M, Gu H, Yi W, Wang C, Luo F, Cao Y, Zhonghua Zhong Liu Za Zhi 2002 24 3 226 229 12515612
46. leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. Saxena NK, Vertino PM, Anania FA, Sharma D, J Biol Chem 2007 282 18 13316 13325 10.1074/jbc.M609798200 17344214 (Pubitemid 47100545)
47. Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity. Lammering G, Hewit TH, Holmes M, Valerie K, Hawkins W, Lin PS, Mikkelsen RB, Schmidt-Ullrich RK, Clin Cancer Res 2004 10 19 6732 6743 10.1158/1078-0432.CCR-04-0393 15475464 (Pubitemid 39346571)
48. Cyclins and cdks in development and cancer: a perspective. Deshpande A, Sicinski P, Hinds PW, Oncogene 2005 24 17 2909 2915 10.1038/sj.onc.1208618 15838524 (Pubitemid 40638099)
49. Nuclear cyclin D1: an oncogenic driver in human cancer. Kim JK, Diehl JA, J Cell Physiol 2009 220 2 292 296 10.1002/jcp.21791 19415697
50. Cyclin D as a therapeutic target in cancer. Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL, Nat Rev Cancer 2011 11 8 558 572 21734724
51. Nasopharyngeal carcinoma-review of the molecular mechanisms of tumorigenesis. Chou J, Lin YC, Kim J, You L, Xu Z, He B, Jablons DM, Head Neck 2008 30 7 946 963 10.1002/hed.20833 18446839 (Pubitemid 352008957)
52. Overproduction of cyclin D1 is dependent on activated mTORC1 signal in nasopharyngeal carcinoma: implication for therapy. Huang XM, Dai CB, Mou ZL, Wang LJ, Wen WP, Lin SG, Xu G, Li HB, Cancer Lett 2009 279 1 47 56 10.1016/j.canlet.2009.01.020 19203829
53. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, et al. Cancer Res 2006 66 5 2544 2552 10.1158/0008-5472.CAN-05-2203 16510571
54. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC, Nat Cell Biol 2001 3 9 802 808 10.1038/ncb0901-802 11533659 (Pubitemid 32842685)
55. Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Lo HW, Hung MC, Br J Cancer 2006 94 2 184 188 10.1038/sj.bjc.6602941 16434982 (Pubitemid 43151532)
56. Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis. Kim DJ, Chan KS, Sano S, Digiovanni J, Mol Carcinog 2007 46 8 725 731 10.1002/mc.20342 17610223 (Pubitemid 47255194)
57. Targeting Stat3 and Smad7 to restore TGF-beta cytostatic regulation of tumor cells in vitro and in vivo. Luwor RB, Baradaran B, Taylor LE, Iaria J, Nheu TV, Amiry N, Hovens CM, Wang B, Kaye AH, Zhu HJ, Oncogene 2013 32 19 2433 2441 10.1038/onc.2012.260 22751114
58. Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3. Kung CP, Raab-Traub N, J Virol 2008 82 11 5486 5493 10.1128/JVI.00125-08 18367518 (Pubitemid 351705255)
59. Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta. Kung CP, Meckes DG Jr, Raab-Traub N, J Virol 2011 85 9 4399 4408 10.1128/JVI.01703-10 21307189
60. Co-regulation of B-Myb expression by E2F1 and EGF receptor. Hanada N, Lo HW, Day CP, Pan Y, Nakajima Y, Hung MC, Mol Carcinog 2006 45 1 10 17 10.1002/mc.20147 16299810 (Pubitemid 43122365)
61. Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression. Hung LY, Tseng JT, Lee YC, Xia W, Wang YN, Wu ML, Chuang YH, Lai CH, Chang WC, Nucleic Acids Res 2008 36 13 4337 4351 10.1093/nar/gkn417 18586824
62. Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes. Lo HW, Cao X, Zhu H, Ali-Osman F, Mol Cancer Res 2010 8 2 232 245 10.1158/1541-7786.MCR-09-0391 20145033
63. STAT1 gene expression is enhanced by nuclear EGFR and HER2 via cooperation with STAT3. Han W, Carpenter RL, Cao X, Lo HW, Mol Carcinog 2012 doi: 10.1002/mc.21936
64. Nuclear mode of the EGFR signaling network: biology, prognostic value, and therapeutic implications. Lo HW, Discov Med 2010 10 50 44 51 20670598
65. Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma. Hoshino M, Fukui H, Ono Y, Sekikawa A, Ichikawa K, Tomita S, Imai Y, Imura J, Hiraishi H, Fujimori T, Pathobiology 2007 74 1 15 21 10.1159/000101047 17496429 (Pubitemid 46742314)
66. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression. Ma N, Kawanishi M, Hiraku Y, Murata M, Huang GW, Huang Y, Luo DZ, Mo WG, Fukui Y, Kawanishi S, Int J Cancer 2008 122 11 2517 2525 10.1002/ijc.23415 18307254 (Pubitemid 351590485)
67. Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions. Ma BB, Hui EP, Chan AT, Cancer Sci 2008 99 7 1311 1318 10.1111/j.1349-7006.2008.00836.x 18498420 (Pubitemid 351761718)
68. Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong nasopharyngeal carcinoma study group. Hui EP, Leung SF, Au JS, Zee B, Tung S, Chua D, Sze WM, Law CK, Leung TW, Chan AT, Cancer 2004 101 2 300 306 10.1002/cncr.20358 15241827 (Pubitemid 38890833)
69. Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells. Lui VW, Yau DM, Wong EY, Ng YK, Lau CP, Ho Y, Chan JP, Hong B, Ho K, Cheung CS, et al. Carcinogenesis 2009 30 12 2085 2094 10.1093/carcin/bgp253 19843642
70. Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response. Ma BB, Lui VW, Poon FF, Wong SC, To KF, Wong E, Chen H, Lo KW, Tao Q, Chan AT, et al. Invest New Drugs 2010 28 3 326 333 10.1007/s10637-009-9316-7 19756373
71. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Siddiquee K, Zhang S, Guida WC, Blaskovich MA, Greedy B, Lawrence HR, Yip ML, Jove R, McLaughlin MM, Lawrence NJ, et al. Proc Natl Acad Sci USA 2007 104 18 7391 7396 10.1073/pnas.0609757104 17463090 (Pubitemid 47185916)
72. A novel inhibitor of STAT3 homodimerization selectively suppresses STAT3 activity and malignant transformation. Zhang X, Sun Y, Pireddu R, Yang H, Urlam MK, Lawrence HR, Guida WC, Lawrence NJ, Sebti SM, Cancer Res 2013 73 6 1922 1933 10.1158/0008-5472.CAN-12-3175 23322008
73. Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth. Nagaraj NS, Washington MK, Merchant NB, Clin Cancer Res 2011 17 3 483 493 10.1158/1078-0432.CCR-10-1670 21266529